In this bidirectional MR study, we discovered that higher levels of genetically determined M-CSF may reduce risk of CRC while higher levels of genetically determined VEGF, IL-12p70, IL-13, IL-10, and IL-7 were linked with increased risk of CRC. The gene discussed is CSF1; the disease is colorectal carcinoma.